Showing results (151-160 of 285) with videos related to

Sort By:
Pageof 29
Blood|October 25, 2003
Long-term outcome of hepatitis C infection after bone marrow transplantationRégis Peffault de Latour, Vincent Lévy, Tarik Asselah, et al.
Hepatology (Baltimore, Md.)|August 31, 2006
Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-upCorinne Castelnau, Frédéric Le Gal, Marie-Pierre Ripault, et al.
Hepatology (Baltimore, Md.)|January 15, 2013
A global view of hepatitis C: physician knowledge, opinions, and perceived barriers to careChristopher E McGowan, Ali Monis, Bruce R Bacon, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 17, 2008
Sustained virological response is associated with clearance of hepatitis C virus RNA and a decrease in hepatitis C virus antibodySarah Maylin, Michelle Martinot-Peignoux, Marie-Pierre Ripault, et al.
Hepatology (Baltimore, Md.)|May 21, 2014
Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis CLaure Elkrief, Pascale Chouinard, Noelle Bendersky, et al.
Gastroenterology|November 2, 2010
Telaprevir is effective given every 8 or 12 hours with ribavirin and peginterferon alfa-2a or -2b to patients with chronic hepatitis CPatrick Marcellin, Xavier Forns, Tobias Goeser, et al.
Journal of Medical Virology|June 2, 2004
The predictive value of core antigen testing for the management of hepatitis C patients receiving pegylated interferon/ribavirin treatmentPierre Pradat, Marianne Maynard, Maria Buti, et al.
Hepatology (Baltimore, Md.)|January 29, 2008
HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis BMichael W Fried, Teerha Piratvisuth, George K K Lau, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 11, 2018
ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg-positive chronic hepatitis BDarren Wong, Margaret Littlejohn, Rosalind Edwards, et al.
Hepatology (Baltimore, Md.)|April 5, 2012
Vaniprevir with pegylated interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C: a randomized phase II studyMichael P Manns, Edward Gane, Maribel Rodriguez-Torres, et al.
Pageof 29